BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27

• Deals

  Medical Device TherOx Cancels IPO

  February 4, 2009

   · 

  1 min read
• Business

  Illumina, Inc. Shares Advance On Larger-Than-Expected 4th Quarter Profit And 2009 Forecasts

  February 4, 2009

   · 

  1 min read
• Drug Development

  Peregrine Pharmaceuticals, Inc.’ Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study

  February 4, 2009

   · 

  5 min read
• Drug Development

  GlaxoSmithKline and Theravance, Inc. Announce Positive Phase 2b Results For Once-Daily Fluticasone Furoate In The Treatment Of Asthma

  February 4, 2009

   · 

  8 min read
• Business

  Neurobiological Technologies, Inc. Announces Appointment of William A. Fletcher as Acting CEO

  February 4, 2009

   · 

  2 min read
• Business

  Roche Holding AG Says Full-Year Net Income Down 5 Percent At $9.3 Billion

  February 4, 2009

   · 

  1 min read
• Pharm Country

  Sequenom Inc. Falls On Down Syndrome Test Data Revision

  February 4, 2009

   · 

  1 min read
• Business

  Sales of Trimeris, Inc.'s Fuzeon fall 39% in 4Q

  February 4, 2009

   · 

  1 min read
• Business

  Perrigo Company Drops After Fiscal 2nd-Quarter Results Miss Estimates, Company Cuts 2009 Forecasts

  February 4, 2009

   · 

  1 min read
• Biotech Beach

  Abraxis BioScience, Inc. Launches ABRAXANE in Germany

  February 4, 2009

   · 

  1 min read